Retatrutide, from Soma Pharmaceuticals , is receiving increasing attention as a novel therapy for weight regulation. This innovative medication combines the mechanism of a GLP-1 receptor agonist and a GIP receptor agonist , designed to simply promote weight loss but also target related metabolic